Candel Therapeutics, Inc.CADLNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-52.10M
↓ 103% below average
Average (5y)
$-25.67M
Historical baseline
Range
High:$-8.99M
Low:$-52.10M
CAGR
+42.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-52.10M | -39.2% |
| 2023 | $-37.43M | -129.5% |
| 2022 | $-16.31M | +36.0% |
| 2021 | $-25.49M | -85.8% |
| 2020 | $-13.72M | -52.5% |
| 2019 | $-8.99M | - |